What are biosimilars and why are pharma companies so bullish on them?

Biosimilars, a pre-defined moonshot sector for the Indian Biopharma industry, is expected to grow over 30 per cent and above by 2047, but needs governmental reforms to burgeon, a recent Confederation of Indian Industry (CII) report said.

Related Keywords

United States ,India ,Umang Vohra ,Indian Biopharma ,Confederation Of Indian Industry ,Cipla ,Indian Industry ,Managing Director ,India Bioeconomy ,Russian Covid ,Biosimilars ,Pharma Companies ,Indian Biopharma Industry ,Dr Reddys Laboratories ,